|
1
|
Bhatia M, Brady M, Shokuhi S, Christmas S,
Neoptolemos JP and Slavin J: Inflammatory mediators in acute
pancreatitis. J Pathol. 190:117–125. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mofidi R, Duff MD, Wigmore SJ, Madhavan
KK, Garden OJ and Parks RW: Association between early systemic
inflammatory response, severity of multiorgan dysfunction and death
in acute pancreatitis. Br J Surg. 93:738–744. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Granger J and Remick D: Acute
pancreatitis: Models, markers and mediators. Shock. 24:45–51. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Papachristou GI, Clermont G, Sharma A,
Yadav D and Whitcomb DC: Risk and markers of severe acute
pancreatitis. Gastroenterol Clin North Am. 36:277–296. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu J, Deng W, Wang W, Ding Y, Jin H, Chen
C, Chen X, Xiong X and Xu S: Inhibition of poly (ADP-ribose)
polymerase attenuates acute kidney injury in sodium
taurocholate-induced acute pancreatitis in rats. Pancreas.
41:1299–1305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rakonczay Z Jr, Hegyi P, Takács T,
McCarroll J and Saluja AK: The role of NF-kappaB activation in the
pathogenesis of acute pancreatitis. Gut. 57:259–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Low TL, Hu SK and Goldstein AL: Complete
amino acid sequence of bovine thymosin beta 4: A thymic hormone
that induces terminal deoxynucleotidyl transferase activity in
thymocyte populations. Proc Natl Acad Sci USA. 78:1162–1166. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hannappel E: Thymosin beta4 and its
posttranslational modifications. Ann N Y Acad Sci. 1194:27–35.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hannappel E and van Kampen M:
Determination of thymosin beta 4 in human blood cells and serum. J
Chromatogr. 397:279–285. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goldstein AL, Hannappel E and Kleinman HK:
Thymosin beta4: Actin-sequestering protein moonlights to repair
injured tissues. Trends Mol Med. 11:421–429. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sosne G, Chan CC, Thai K, Kennedy M,
Szliter EA, Hazlett LD and Kleinman HK: Thymosin beta 4 promotes
corneal wound healing and modulates inflammatory mediators in vivo.
Exp Eye Res. 72:605–608. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Badamchian M, Fagarasan MO, Danner RL,
Suffredini AF, Damavandy H and Goldstein AL: Thymosin beta (4)
reduces lethality and down-regulates inflammatory mediators in
endotoxin-induced septic shock. Int Immunopharmacol. 3:1225–1233.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sosne G, Christopherson PL, Barrett RP and
Fridman R: Thymosin-beta4 modulates corneal matrix
metalloproteinase levels and polymorphonuclear cell infiltration
after alkali injury. Invest Ophthalmol Vis Sci. 46:2388–2395. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sosne G, Szliter EA, Barrett R, Kernacki
KA, Kleinman H and Hazlett LD: Thymosin beta 4 promotes corneal
wound healing and decreases inflammation in vivo following alkali
injury. Exp Eye Res. 74:293–299. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sosne G, Qiu P, Christopherson PL and
Wheater MK: Thymosin beta 4 suppression of corneal NFkappaB: A
potential anti-inflammatory pathway. Exp Eye Res. 84:663–669. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu P, Wheater MK, Qiu Y and Sosne G:
Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation,
IL-8 expression and the sensitizing effects by its partners PINCH-1
and ILK. FASEB J. 25:1815–1826. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malinda KM, Goldstein AL and Kleinman HK:
Thymosin beta 4 stimulates directional migration of human umbilical
vein endothelial cells. FASEB J. 11:474–481. 1997.PubMed/NCBI
|
|
18
|
Grant DS, Rose W, Yaen C, Goldstein A,
Martinez J and Kleinman H: Thymosin beta4 enhances endothelial cell
differentiation and angiogenesis. Angiogenesis. 3:125–135. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Treadwell T, Kleinman HK, Crockford D,
Hardy MA, Guarnera GT and Goldstein AL: The regenerative peptide
thymosin β4 accelerates the rate of dermal healing in preclinical
animal models and in patients. Ann N Y Acad Sci. 1270:37–44. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Crockford D: Development of thymosin beta4
for treatment of patients with ischemic heart disease. Ann NY Acad
Sci. 1112:385–395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiong Y, Mahmood A, Meng Y, Zhang Y, Zhang
ZG, Morris DC and Chopp M: Treatment of traumatic brain injury with
thymosin β4 in rats. J Neurosurg. 114:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiong Y, Zhang Y, Mahmood A, Meng Y, Zhang
ZG, Morris DC and Chopp M: Neuroprotective and neurorestorative
effects of thymosin β4 treatment initiated 6 h after traumatic
brain injury in rats. J Neurosurg. 116:1081–1092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schmidt J, Rattner DW, Lewandrowski K,
Compton CC, Mandavilli U, Knoefel WT and Warshaw AL: A better model
of acute pancreatitis for evaluating therapy. Ann Surg. 215:44–56.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakae H, Endo S, Sato N, Wakabayashi G,
Inada K and Sato S: Involvement of soluble adhesion molecules in
acute pancreatitis. Eur Surg Res. 33:377–382. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sah RP, Dawra RK and Saluja AK: New
insights into the pathogenesis of pancreatitis. Curr Opin
Gastroenterol. 29:523–530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Girardi M, Sherling MA, Filler RB, Shires
J, Theodoridis E, Hayday AC and Tigelaar RE: Anti-inflammatory
effects in the skin of thymosin-beta4 splice-variants. Immunology.
109:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hinkel R, Trenkwalder T and Kupatt C:
Molecular and cellular mechanisms of thymosin β4-mediated
cardioprotection. Ann NY Acad Sci. 1269:102–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bock-Marquette I, Saxena A, White MD,
Dimaio JM and Srivastava D: Thymosin beta4 activates
integrin-linked kinase and promotes cardiac cell migration,
survival and cardiac repair. Nature. 432:466–472. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shrivastava S, Srivastava D, Olson EN,
DiMaio JM and Bock-Marquette I: Thymosin beta4 and cardiac repair.
Ann NY Acad Sci. 1194:87–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Philp D, Badamchian M, Scheremeta B,
Nguyen M, Goldstein AL and Kleinman HK: Thymosin beta 4 and a
synthetic peptide containing its actin-binding domain promote
dermal wound repair in db/db diabetic mice and in aged mice. Wound
Repair Regen. 11:19–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Zhang ZG, Morris D, Li Y, Roberts
C, Elias SB and Chopp M: Neurological functional recovery after
thymosin beta4 treatment in mice with experimental auto
encephalomyelitis. Neuroscience. 164:1887–1893. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen X, Ji B, Han B, Ernst SA, Simeone D
and Logsdon CD: NF-kappaB activation in pancreas induces pancreatic
and systemic inflammatory response. Gastroenterology. 122:448–457.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang H, Liu Y, Daniluk J, Gaiser S, Chu
J, Wang H, Li ZS, Logsdon CD and Ji B: Activation of nuclear
factor-κB in acinar cells increases the severity of pancreatitis in
mice. Gastroenterology. 144:202–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baldwin AS Jr: The NF-kappaB and I kappaB
proteins: New discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim H, Seo JY, Roh KH, Lim JW and Kim KH:
Suppression of NF-kappaB activation and cytokine production by
N-acetylcysteine in pancreatic acinar cells. Free Radic Biol Med.
29:674–683. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Telek G, Ducroc R, Scoazec JY, Pasquier C,
Feldmann G and Rozé C: Differential upregulation of cellular
adhesion molecules at the sites of oxidative stress in experimental
acute pancreatitis. J Surg Res. 96:56–67. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Surbatovic M and Radakovic S: Tumor
necrosis factor-α levels early in severe acute pancreatitis: Is
there predictive value regarding severity and outcome? J Clin
Gastroenterol. 47:637–643. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Malmstrøm ML, Hansen MB, Andersen AM,
Ersbøll AK, Nielsen OH, Jørgensen LN and Novovic S: Cytokines and
organ failure in acute pancreatitis: Inflammatory response in acute
pancreatitis. Pancreas. 41:271–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Makhija R and Kingsnorth AN: Cytokine
storm in acute pancreatitis. J Hepatobiliary Pancreat Surg.
9:401–410. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vonlaufen A, Apte MV, Imhof BA and
Frossard JL: The role of inflammatory and parenchymal cells in
acute pancreatitis. J Pathol. 213:239–248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mota R, Sánchez-Bueno F, Berenguer-Pina
JJ, Hernández-Espinosa D, Parrilla P and Yélamos J: Therapeutic
treatment with poly(ADP-ribose) polymerase inhibitors attenuates
the severity of acute pancreatitis and associated liver and lung
injury. Br J Pharmacol. 151:998–1005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen C, Xu S, Wang WX, Ding YM, Yu KH,
Wang B and Chen XY: Rosiglitazone attenuates the severity of sodium
taurocholate-induced acute pancreatitis and pancreatitis-associated
lung injury. Arch Med Res. 40:79–88. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chooklin S, Pereyaslov A and Bihalskyy I:
Pathogenic role of myeloperoxidase in acute pancreatitis.
Hepatobiliary Pancreat Dis Int. 8:627–631. 2009.PubMed/NCBI
|
|
44
|
Werner J, Z'graggen K, Castillo
Fernández-del C, Lewandrowski KB, Compton CC and Warshaw AL:
Specific therapy for local and systemic complications of acute
pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg.
229:834–842. 1999. View Article : Google Scholar : PubMed/NCBI
|
